Understanding factors, outcomes and reasons for loss to follow‐up among women in O ption B+ PMTCT programme in L ilongwe, M alawi

H Tweya, S Gugsa, M Hosseinipour… - Tropical Medicine & …, 2014 - Wiley Online Library
Objective To assess factors, outcomes and reasons for loss to follow‐up (LTFU) among
pregnant and breastfeeding women initiated on a lifelong antiretroviral therapy (ART) for …

Retention in care and reasons for discontinuation of lifelong antiretroviral therapy in a cohort of Cameroonian pregnant and breastfeeding HIV‐positive women …

PN Atanga, HT Ndetan, EA Achidi… - Tropical Medicine & …, 2017 - Wiley Online Library
Objective To assess linkage and retention in care along the PMTCT cascade in HIV‐positive
pregnant and breastfeeding women initiating Option B+ in Cameroon. Methods We …

Vulnerable at each step in the PMTCT care cascade: high loss to follow up during pregnancy and the postpartum period in Tanzania

C Cichowitz, F Mazuguni, L Minja, P Njau… - AIDS and Behavior, 2019 - Springer
Abstract In 2013, Tanzania adopted the World Health Organization's Option B+ guidelines
for prevention of mother-to-child transmission of HIV (PMTCT), whereby all HIV-infected …

Retention in care under universal antiretroviral therapy for HIV-infected pregnant and breastfeeding women ('Option B+') in Malawi

L Tenthani, AD Haas, H Tweya, A Jahn… - Aids, 2014 - journals.lww.com
Objective: To explore the levels and determinants of loss to follow-up (LTF) under universal
lifelong antiretroviral therapy (ART) for pregnant and breastfeeding women ('Option B+') in …

Factors associated with loss to follow‐up among women in Option B+ PMTCT programme in northeast Ethiopia: a retrospective cohort study

I Mitiku, M Arefayne, Y Mesfin… - African Journal of …, 2016 - journals.lww.com
Introduction: Ethiopia has recently adopted lifelong antiretroviral therapy (ART) for all HIV-
positive pregnant and breastfeeding women (Option B'strategy), regardless of CD4 count or …

Retention in care during the first 3 years of antiretroviral therapy for women in Malawi's option B+ programme: an observational cohort study

AD Haas, L Tenthani, MT Msukwa, K Tal, A Jahn… - The lancet HIV, 2016 - thelancet.com
Summary Background Studies of Malawi's option B+ programme for HIV-positive pregnant
and breastfeeding women have reported high loss to follow-up during pregnancy and at the …

Facilitators and barriers to uptake and adherence to lifelong antiretroviral therapy among HIV infected pregnant women in Uganda: a qualitative study

E Buregyeya, R Naigino, A Mukose, F Makumbi… - BMC pregnancy and …, 2017 - Springer
Abstract Background In 2012, Uganda started implementing lifelong antiretroviral therapy
(ART) for prevention of mother to child transmission (PMTCT) in line with the WHO 2012 …

Retention of HIV infected pregnant and breastfeeding women on option B+ in Gomba District, Uganda: a retrospective cohort study

G Kiwanuka, N Kiwanuka, F Muneza, J Nabirye… - BMC infectious …, 2018 - Springer
Background Lifelong antiretroviral therapy for HIV infected pregnant and lactating women
(Option B+) has been rapidly scaled up but there are concerns about poor retention of …

Initiation of highly active antiretroviral therapy among pregnant women in Cape Town, South Africa

K Stinson, A Boulle, D Coetzee… - Tropical Medicine & …, 2010 - Wiley Online Library
Objective To investigate highly active antiretroviral therapy (HAART) initiation among
pregnant women and the optimum model of service delivery for integrating HAART services …

Frequency and factors associated with adherence to and completion of combination antiretroviral therapy for prevention of mother to child transmission in western …

P Ayuo, B Musick, H Liu, P Braitstein… - African Journal of …, 2013 - journals.lww.com
Introduction: The objective of this analysis was to identify points of disruption within the
prevention of mother-to-child transmission (PMTCT) continuum from combination …